A detailed history of Gabelli Funds LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Gabelli Funds LLC holds 402,396 shares of BSX stock, worth $39.7 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
402,396
Previous 183,526 119.26%
Holding current value
$39.7 Million
Previous $14.1 Million 138.59%
% of portfolio
0.26%
Previous 0.12%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $16 Million - $18.4 Million
218,870 Added 119.26%
402,396 $33.7 Million
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $5.98 Million - $6.9 Million
88,826 Added 93.8%
183,526 $14.1 Million
Q1 2024

May 14, 2024

SELL
$57.6 - $68.62 $1.2 Million - $1.43 Million
-20,800 Reduced 18.01%
94,700 $6.49 Million
Q4 2023

Feb 13, 2024

SELL
$48.64 - $57.81 $753,920 - $896,055
-15,500 Reduced 11.83%
115,500 $6.68 Million
Q3 2023

Nov 08, 2023

SELL
$50.19 - $54.68 $125,475 - $136,700
-2,500 Reduced 1.87%
131,000 $6.92 Million
Q2 2023

Aug 10, 2023

SELL
$49.72 - $54.64 $303,292 - $333,304
-6,100 Reduced 4.37%
133,500 $7.22 Million
Q1 2023

May 12, 2023

SELL
$45.09 - $50.03 $514,026 - $570,342
-11,400 Reduced 7.55%
139,600 $6.98 Million
Q4 2022

Feb 13, 2023

SELL
$39.56 - $47.22 $316,480 - $377,760
-8,000 Reduced 5.03%
151,000 $6.99 Million
Q3 2022

Nov 10, 2022

SELL
$36.71 - $109.66 $146,840 - $438,640
-4,000 Reduced 2.45%
159,000 $6.16 Million
Q3 2021

Nov 12, 2021

SELL
$41.23 - $45.88 $206,149 - $229,400
-5,000 Reduced 2.98%
163,000 $7.07 Million
Q2 2021

Aug 13, 2021

SELL
$38.58 - $44.24 $848,760 - $973,280
-22,000 Reduced 11.58%
168,000 $7.18 Million
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $529,050 - $595,050
-15,000 Reduced 7.32%
190,000 $7.34 Million
Q4 2020

Feb 05, 2021

SELL
$33.15 - $41.97 $397,800 - $503,640
-12,000 Reduced 5.53%
205,000 $7.37 Million
Q3 2020

Nov 06, 2020

SELL
$34.44 - $42.23 $137,760 - $168,920
-4,000 Reduced 1.81%
217,000 $8.29 Million
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $181,140 - $234,660
6,000 Added 2.79%
221,000 $7.76 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $1.44 Million - $1.72 Million
-38,000 Reduced 15.02%
215,000 $9.72 Million
Q3 2019

Nov 01, 2019

SELL
$40.31 - $43.45 $644,960 - $695,200
-16,000 Reduced 5.95%
253,000 $10.3 Million
Q2 2019

Aug 02, 2019

SELL
$34.91 - $42.98 $628,379 - $773,640
-18,000 Reduced 6.27%
269,000 $11.6 Million
Q1 2019

May 02, 2019

SELL
$32.91 - $40.75 $1.63 Million - $2.01 Million
-49,400 Reduced 14.68%
287,000 $11 Million
Q4 2018

Jan 30, 2019

SELL
$31.73 - $39.04 $145,958 - $179,584
-4,600 Reduced 1.35%
336,400 $11.9 Million
Q3 2018

Nov 02, 2018

SELL
$32.83 - $38.63 $32,830 - $38,630
-1,000 Reduced 0.29%
341,000 $13.1 Million
Q2 2018

Aug 10, 2018

SELL
$26.84 - $34.32 $1.56 Million - $1.99 Million
-58,000 Reduced 14.5%
342,000 $11.2 Million
Q1 2018

May 09, 2018

SELL
$25.2 - $28.54 $50,400 - $57,080
-2,000 Reduced 0.5%
400,000 $10.9 Million
Q4 2017

Feb 02, 2018

SELL
$24.79 - $29.8 $1.02 Million - $1.22 Million
-41,000 Reduced 9.26%
402,000 $9.97 Million
Q3 2017

Nov 01, 2017

BUY
$26.26 - $29.17 $11.6 Million - $12.9 Million
443,000
443,000 $12.9 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.